PMC:7784824 / 7447-7949 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"151","span":{"begin":364,"end":374},"obj":"Species"},{"id":"152","span":{"begin":484,"end":494},"obj":"Species"},{"id":"153","span":{"begin":250,"end":258},"obj":"Disease"},{"id":"154","span":{"begin":413,"end":421},"obj":"Disease"},{"id":"155","span":{"begin":444,"end":452},"obj":"Disease"}],"attributes":[{"id":"A151","pred":"tao:has_database_id","subj":"151","obj":"Tax:2697049"},{"id":"A152","pred":"tao:has_database_id","subj":"152","obj":"Tax:2697049"},{"id":"A153","pred":"tao:has_database_id","subj":"153","obj":"MESH:C000657245"},{"id":"A154","pred":"tao:has_database_id","subj":"154","obj":"MESH:C000657245"},{"id":"A155","pred":"tao:has_database_id","subj":"155","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The main goal of this study was to evaluate the performance of 5 five Point-Of-Care antibody Tests, one chemiluminescence microparticle immunoassay (CMIA), one chemiluminescence immunoassay (CLIA) and 7 enzyme-linked immunosorbent assays (ELISA) for COVID-19 serology in an attempt to validate and select the best performing ones. Secondly, we discuss the role of SARS-CoV-2 serology in the process of diagnosing COVID-19 disease in presumable COVID-19 cases with sequential negative SARS-CoV-2 RT-PCR."}

{"project":"LitCovid-sentences","denotations":[{"id":"T81","span":{"begin":0,"end":330},"obj":"Sentence"},{"id":"T82","span":{"begin":331,"end":502},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The main goal of this study was to evaluate the performance of 5 five Point-Of-Care antibody Tests, one chemiluminescence microparticle immunoassay (CMIA), one chemiluminescence immunoassay (CLIA) and 7 enzyme-linked immunosorbent assays (ELISA) for COVID-19 serology in an attempt to validate and select the best performing ones. Secondly, we discuss the role of SARS-CoV-2 serology in the process of diagnosing COVID-19 disease in presumable COVID-19 cases with sequential negative SARS-CoV-2 RT-PCR."}